40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy
Assaf Moore,Zhigang Zhang,Teng Fei,Lei Zhang,Laura Accomando,Adam M Schmitt,Daniel S Higginson,Boris A Mueller,Melissa Zinovoy,Daphna Y Gelblum,Divya Yerramilli,Amy J Xu,Victoria S Brennan,David M Guttmann,Craig E Grossman,Laura L Dover,Narek Shaverdian,Luke R G Pike,John J Cuaron,Alexandra Dreyfuss,Eric Lis,Ori Barzilai,Mark H Bilsky,Yoshiya Yamada,Adam M. Schmitt,Daniel S. Higginson,Boris A. Mueller,Daphna Y. Gelblum,Amy J. Xu,Victoria S. Brennan,David M. Guttmann,Craig E. Grossman,Laura L. Dover,Luke R. G. Pike,John J. Cuaron,Mark H. Bilsky
DOI: https://doi.org/10.1227/neu.0000000000002889
IF: 5.315
2024-03-08
Neurosurgery
Abstract:BACKGROUND AND PURPOSE: A retrospective single-center analysis of the safety and efficacy of reirradiation to 40 Gy in 5 fractions (reSBRT) in patients previously treated with stereotactic body radiotherapy to the spine was performed. METHODS: We identified 102 consecutive patients treated with reSBRT for 105 lesions between 3/2013 and 8/2021. Sixty-three patients (61.8%) were treated to the same vertebral level, and 39 (38.2%) to overlapping immediately adjacent levels. Local control was defined as the absence of progression within the treated target volume. The probability of local progression was estimated using a cumulative incidence curve. Death without local progression was considered a competing risk. RESULTS: Most patients had extensive metastatic disease (54.9%) and were treated to the thoracic spine (53.8%). The most common regimen in the first course of stereotactic body radiotherapy was 27 Gy in 3 fractions, and the median time to reSBRT was 16.4 months. At the time of simulation, 44% of lesions had advanced epidural disease. Accordingly, 80% had myelogram simulations. Both the vertebral body and posterior elements were treated in 86% of lesions. At a median follow-up time of 13.2 months, local failure occurred in 10 lesions (9.5%). The 6- and 12-month cumulative incidences of local failure were 4.8% and 6%, respectively. Seven patients developed radiation-related neuropathy, and 1 patient developed myelopathy. The vertebral compression fracture rate was 16.7%. CONCLUSION: In patients with extensive disease involvement, reSBRT of spine metastases with 40 Gy in 5 fractions seems to be safe and effective. Prospective trials are needed to determine the optimal dose and fractionation in this clinical scenario.
surgery,clinical neurology